Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Argus Health

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,935,507

« Back to Dashboard

Summary for Patent: 4,935,507

Title: Crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-c arboxylic acid (syn isomer)
Abstract:The invention relates to crystalline 7-[2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3-vinyl-3-cephem-4-car boxylic acid (syn isomer) useful as an antimicrobial agent.
Inventor(s): Takaya; Takao (Kawanishi, JP), Shirai; Fumiyuki (Ikeda, JP), Nakamura; Hitoshi (Mino, JP), Inaba; Yasunobu (Toyonaka, JP)
Assignee: Fujisawa Pharmaceutical Co., Ltd. (Osaka, JP)
Application Number:07/229,489
Patent Claim Types:
see list of patent claims
Compound; Formulation;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,935,507

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan62-206199Aug 19, 1987

International Patent Family for Patent: 4,935,507

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria123221► Subscribe
Australia617347► Subscribe
Canada1297096► Subscribe
Germany3853901► Subscribe
European Patent Office0304019► Subscribe
Spain2072856► Subscribe
Hong Kong18496► Subscribe
Ireland67348► Subscribe
Ireland882411► Subscribe
JapanH01250384► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
Fish and Richardson
Express Scripts
Chinese Patent Office
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: